African American men face many different health disparities with most of the disparities being weighed against them. There is one notable exception, African American (AA) men have a huge, significant overall survival benefit when given Sipuleucel-T (Provenge) equal to 9.5 months over their Caucasian counterparts!
Why you should take Provenge (sipuleucel-T) simply using evidence based logic.
Provenge (Sipuleucel-T) is the first FDA approved cancer vaccine and it is still the only immune therapy approved for Prostate Cancer. In a post-hoc analysis it was demonstrated that those men who have lower PSA scores had a superior overall survival. The analysis also showed that men who had Provenge treatment have a lower risk of cardiovascular events.
Getting Provenge is a two step process, understanding what to expect will make your experience easier. You will also need to make some decisions about how you want to get it.
In a prospective, real-world analysis, it was shown that African American men, who have castrate resistant, metastatic prostate cancer, benefited receiving an additional overall survival (OS) benefit when they received Sipuleucel-T (Provenge).